161 related articles for article (PubMed ID: 22684085)
21. Expansion of CD4+CD25+FOXP3+ regulatory T cells in infants of mothers with type 1 diabetes.
Luopajärvi K; Nieminen JK; Ilonen J; Akerblom HK; Knip M; Vaarala O
Pediatr Diabetes; 2012 Aug; 13(5):400-7. PubMed ID: 22332874
[TBL] [Abstract][Full Text] [Related]
22. Antigen-specific prevention of type 1 diabetes in NOD mice is ameliorated by OX40 agonist treatment.
Bresson D; Fousteri G; Manenkova Y; Croft M; von Herrath M
J Autoimmun; 2011 Dec; 37(4):342-51. PubMed ID: 22063316
[TBL] [Abstract][Full Text] [Related]
23. Frequency and activation of CD4+CD25 FoxP3+ regulatory T cells in peripheral blood from children with atopic allergy.
Stelmaszczyk-Emmel A; Zawadzka-Krajewska A; Szypowska A; Kulus M; Demkow U
Int Arch Allergy Immunol; 2013; 162(1):16-24. PubMed ID: 23817221
[TBL] [Abstract][Full Text] [Related]
24. Decreased suppression of CD8
Giri PS; Dwivedi M; Begum R
Exp Dermatol; 2020 Aug; 29(8):759-775. PubMed ID: 32682346
[TBL] [Abstract][Full Text] [Related]
25. Defects in IL-2R signaling contribute to diminished maintenance of FOXP3 expression in CD4(+)CD25(+) regulatory T-cells of type 1 diabetic subjects.
Long SA; Cerosaletti K; Bollyky PL; Tatum M; Shilling H; Zhang S; Zhang ZY; Pihoker C; Sanda S; Greenbaum C; Buckner JH
Diabetes; 2010 Feb; 59(2):407-15. PubMed ID: 19875613
[TBL] [Abstract][Full Text] [Related]
26. Lower proportions of CD4+CD25(high) and CD4+FoxP3, but not CD4+CD25+CD127(low) FoxP3+ T cell levels in children with autoimmune thyroid diseases.
Bossowski A; Moniuszko M; Dąbrowska M; Sawicka B; Rusak M; Jeznach M; Wójtowicz J; Bodzenta-Lukaszyk A; Bossowska A
Autoimmunity; 2013 May; 46(3):222-30. PubMed ID: 23249428
[TBL] [Abstract][Full Text] [Related]
27. CD4(+) CD25(low) GITR(+) cells: a novel human CD4(+) T-cell population with regulatory activity.
Bianchini R; Bistoni O; Alunno A; Petrillo MG; Ronchetti S; Sportoletti P; Bocci EB; Nocentini G; Gerli R; Riccardi C
Eur J Immunol; 2011 Aug; 41(8):2269-78. PubMed ID: 21557210
[TBL] [Abstract][Full Text] [Related]
28. HSP70 enhances immunosuppressive function of CD4(+)CD25(+)FoxP3(+) T regulatory cells and cytotoxicity in CD4(+)CD25(-) T cells.
Wachstein J; Tischer S; Figueiredo C; Limbourg A; Falk C; Immenschuh S; Blasczyk R; Eiz-Vesper B
PLoS One; 2012; 7(12):e51747. PubMed ID: 23300563
[TBL] [Abstract][Full Text] [Related]
29. Changes of regulatory T cells and FoxP3 gene expression in the aging process and its relationship with lung tumors in humans and mice.
Pan XD; Mao YQ; Zhu LJ; Li J; Xie Y; Wang L; Zhang GB
Chin Med J (Engl); 2012 Jun; 125(11):2004-11. PubMed ID: 22884069
[TBL] [Abstract][Full Text] [Related]
30. Differences of Circulating CD25
Zhang J; Fu Q; He Y; Lv H; Qian Y; Zhang Y; Chen H; Xu X; Yang T; Xu K
J Immunol Res; 2022; 2022():2269237. PubMed ID: 35083339
[TBL] [Abstract][Full Text] [Related]
31. Peripheral blood regulatory T cells in patients with diffuse systemic sclerosis (SSc) before and after autologous hematopoietic SCT: a pilot study.
Baraut J; Grigore EI; Jean-Louis F; Khelifa SH; Durand C; Verrecchia F; Farge D; Michel L
Bone Marrow Transplant; 2014 Mar; 49(3):349-54. PubMed ID: 24362364
[TBL] [Abstract][Full Text] [Related]
32. Expression of CD4+CD25+CD127
Zhou W; Deng J; Chen Q; Li R; Xu X; Guan Y; Li W; Xiong X; Li H; Li J; Cai X
Int J Med Sci; 2020; 17(6):712-719. PubMed ID: 32218692
[No Abstract] [Full Text] [Related]
33. Identification, frequency, activation and function of CD4+ CD25(high)FoxP3+ regulatory T cells in children with juvenile idiopathic arthritis.
Stelmaszczyk-Emmel A; Jackowska T; Rutkowska-Sak L; Marusak-Banacka M; Wąsik M
Rheumatol Int; 2012 May; 32(5):1147-54. PubMed ID: 21249500
[TBL] [Abstract][Full Text] [Related]
34. Expansion of human regulatory T-cells from patients with type 1 diabetes.
Putnam AL; Brusko TM; Lee MR; Liu W; Szot GL; Ghosh T; Atkinson MA; Bluestone JA
Diabetes; 2009 Mar; 58(3):652-62. PubMed ID: 19074986
[TBL] [Abstract][Full Text] [Related]
35. IL-33 Effect on Quantitative Changes of CD4
Ryba-Stanisławowska M; Werner P; Skrzypkowska M; Brandt A; Myśliwska J
Mediators Inflamm; 2016; 2016():9429760. PubMed ID: 27761063
[TBL] [Abstract][Full Text] [Related]
36. Impact of CD4+CD25high regulatory T-cells and FoxP3 expression in the peripheral blood of patients with systemic lupus erythematosus.
Atfy M; Amr GE; Elnaggar AM; Labib HA; Esh A; Elokely AM
Egypt J Immunol; 2009; 16(1):117-26. PubMed ID: 20726328
[TBL] [Abstract][Full Text] [Related]
37. A modified flow cytometry method for objective estimation of human CD4
Petsiou A; Paschou SA; Vartholomatos G; Chatzigianni K; Kolaitis N; Giotaki E; Bondinas GP; Moustakas AK; Karamoutsios A; Zervou E; Tigas S; Tsatsoulis A; Papadopoulos GK
Cytometry B Clin Cytom; 2020 May; 98(3):259-269. PubMed ID: 31571372
[TBL] [Abstract][Full Text] [Related]
38. Circulating CD4+CD25 high regulatory T cells and natural killer T cells in children with newly diagnosed type 1 diabetes or with diabetes-associated autoantibodies.
Oling V; Marttila J; Knip M; Simell O; Ilonen J
Ann N Y Acad Sci; 2007 Jun; 1107():363-72. PubMed ID: 17804564
[TBL] [Abstract][Full Text] [Related]
39. Defective response of CD4(+) T cells to retinoic acid and TGFβ in systemic lupus erythematosus.
Sobel ES; Brusko TM; Butfiloski EJ; Hou W; Li S; Cuda CM; Abid AN; Reeves WH; Morel L
Arthritis Res Ther; 2011 Jun; 13(3):R106. PubMed ID: 21708033
[TBL] [Abstract][Full Text] [Related]
40. Dynamic changes in CD4+ CD25+(high) T cell apoptosis after the diagnosis of type 1 diabetes.
Glisic-Milosavljevic S; Wang T; Koppen M; Kramer J; Ehlenbach S; Waukau J; Jailwala P; Jana S; Alemzadeh R; Ghosh S
Clin Exp Immunol; 2007 Oct; 150(1):75-82. PubMed ID: 17711492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
